Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Timolol recalled?

Yes — there is an active recall. 14 ongoing FDA recalls mention Timolol (34 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Timolol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Timolol recalls on record

none so far in 2026; 34 on record, newest first
Class II · Moderate risk

Timolol-Latanoprost PF Solution

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Terminated Chemical / undeclared ImprimisRx CA, Inc., dba ImprimisRx D-1132-2017
Class III · Low risk

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-141-10 D-1073-2014
Class III · Low risk

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-141-50 D-1072-2014
Class III · Low risk

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-140-10 D-1071-2014
Class III · Low risk

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-140-50 D-1070-2014